However, in the AKI model, renal function recovery and tubular regeneration were both significantly delayed when treated with EGFR tyrosine kinase inhibitor or in the setting of EGFR mutation that induces a reduction in receptor tyrosine kinase activity [19,20]. Here, EGFR is linked to acute kidney injury.